Capital Fund Management (CFM)
TMO icon

Capital Fund Management (CFM)’s Thermo Fisher Scientific TMO Stock Holding History

Capital Fund Management (CFM)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
64,723
+42,518
+191% +$20.4M 0.14% 160
2026
Q1 		$10.9M Buy
+22,205
New +$12.1M 0.05% 518
2025
Q3 		– Sell
-131,832
Closed -$61.4M – 2683
2025
Q2 		$53.5M Buy
131,832
+110,073
+506% +$46M 0.15% 195
2025
Q1 		$10.8M Sell
21,759
-32,965
-60% -$17.9M 0.03% 643
2024
Q4 		$28.5M Buy
54,724
+10,668
+24% +$5.87M 0.07% 372
2024
Q3 		$27.3M Sell
44,056
-7,475
-15% -$4.42M 0.07% 347
2024
Q2 		$28.5M Buy
51,531
+37,623
+271% +$21.6M 0.08% 316
2024
Q1 		$8.08M Buy
+13,908
New +$7.8M 0.02% 835
2019
Q2 		– Sell
-1,709
Closed -$471K – 1919
2019
Q1 		$468K Sell
1,709
-12,804
-88% -$3.19M ﹤0.01% 1276
2018
Q4 		$3.25M Buy
+14,513
New +$3.41M 0.03% 661
2018
Q1 		– Sell
-11,396
Closed -$2.16M – 2176
2017
Q4 		$2.16M Buy
+11,396
New +$2.18M 0.01% 955
2017
Q3 		– Sell
-27,981
Closed -$5.07M – 1748
2017
Q2 		$4.88M Sell
27,981
-87,790
-76% -$14.7M 0.04% 474
2017
Q1 		$17.8M Buy
+115,771
New +$17.7M 0.15% 174
2014
Q4 		– Sell
-8,426
Closed -$1.02M – 1800
2014
Q3 		$1.02M Buy
+8,426
New +$1.02M 0.01% 920
2014
Q2 		– Sell
-26,875
Closed -$3.16M – 1935
2014
Q1 		$3.23M Buy
+26,875
New +$3.2M 0.04% 501

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Fund Management (CFM)'s TMO Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Thermo Fisher Scientific (TMO) stake by 191% in Q2 2026, buying an estimated $20.4M and bringing the position to 64,723 shares worth $32.4M. The position accounts for 0.14% of the portfolio, ranked #160.

Capital Fund Management (CFM) first reported a position in TMO in Q1 2014 and has held it in 15 quarters since. The position peaked at $53.5M in Q2 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital Fund Management (CFM) held 64,723 shares of Thermo Fisher Scientific worth $32.4M as of Q2 2026.
  • Capital Fund Management (CFM) bought 42,518 Thermo Fisher Scientific shares in Q2 2026, an estimated $20.4M.
  • Thermo Fisher Scientific made up 0.14% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #160 holding.
  • Capital Fund Management (CFM) first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 15 quarters since.
  • Capital Fund Management (CFM)'s Thermo Fisher Scientific position peaked at $53.5M in Q2 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.